Targeting IκappaB kinases for cancer therapy

Seminars in Cancer Biology
Nikee AwastheeSubash C Gupta

Abstract

The inhibitory kappa B kinases (IKKs) and IKK related kinases are crucial regulators of the pro-inflammatory transcription factor, nuclear factor kappa B (NF-κB). The dysregulation in the activities of these kinases has been reported in several cancer types. These kinases are known to regulate survival, proliferation, invasion, angiogenesis, and metastasis of cancer cells. Thus, IKK and IKK related kinases have emerged as an attractive target for the development of cancer therapeutics. Several IKK inhibitors have been developed, few of which have advanced to the clinic. These inhibitors target IKK either directly or indirectly by modulating the activities of other signaling molecules. Some inhibitors suppress IKK activity by disrupting the protein-protein interaction in the IKK complex. The inhibition of IKK has also been shown to enhance the efficacy of conventional chemotherapeutic agents. Because IKK and NF-κB are the key components of innate immunity, suppressing IKK is associated with the risk of immune suppression. Furthermore, IKK inhibitors may hit other signaling molecules and thus may produce off-target effects. Recent studies suggest that multiple cytoplasmic and nuclear proteins distinct from NF-κB and inhibitory κB...Continue Reading

Citations

Jan 1, 2019·Journal of Pineal Research·Tian LiYang Yang
May 15, 2020·PloS One·Hope MurphyHana M Dobrovolny
Nov 11, 2018·Cancers·Justyna Struzik, Lidia Szulc-Dąbrowska
Nov 27, 2018·Cancer Cell International·Xiaojun ZhouFeng Guo
Oct 23, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·Subash C GuptaKishore B Challagundla
Nov 18, 2020·Biomolecules·Andrea Baier, Ryszard Szyszka
Feb 3, 2021·Antioxidants·Peter F SuraiMichael T Kidd
May 1, 2021·Nature Cancer·Christine S MoonAdolfo A Ferrando
Sep 20, 2020·Biochimica Et Biophysica Acta. Molecular Cell Research·Xueqiang PengHangyu Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Dung-Fang Lee, Mien-Chie Hung
Expert Opinion on Drug Metabolism & Toxicology
Maria C Shoshan, Stig Linder
© 2022 Meta ULC. All rights reserved